View:
0;
July 20,
2009
Via
Edgar Submission
Mr.
Jeffrey P. Riedler, Ass’t. Director
United
States Securities and Exchange Commission
100 F
Street, N.E.
Washington,
D.C. 20549
Re: BioScrip, Inc.
Form 10-K for the Year Ended December
31, 2008
Filed March 5, 2009
File No. 000-28740
Dear
Sir:
This
letter shall serve to confirm the BioScrip, Inc.’s receipt of the Commission’s
comment letter, dated July 16, 2009 and received at our offices via telecopier
on July 17, 2009. Per your request and my conversations with Michael
McGowan of the Commission’s Division of Corporation Finance, BioScrip shall file
its response via EDGAR (and filed as CORRESP) on or before August 14,
2009.
Please do
not hesitate to contact the undersigned as primary company contact as
necessary.
Sincerely
yours,
\s\ Barry A.
Posner
Barry A.
Posner